Varicose veins affect a significant portion of the population and can cause pain, swelling, skin changes and venous stasis ulcers if left untreated. Traditionally, treatments for varicose veins involved invasive surgery. However, advances in medical technology have paved the way for minimally invasive outpatient procedures using specialized varicose vein treatment devices. These modern treatment options are allowing more patients to effectively manage their varicose veins.
Endovenous Laser Ablation (EVLA)
One of the most commonly used varicose vein treatment devices today is the endovenous laser system. EVLA uses laser energy delivered through a thin fiber optic cable inserted into the diseased vein to close it. The laser damages the inner lining of the vein, causing it to seal shut and eventually be reabsorbed by the body. This minimally invasive procedure is performed as an outpatient treatment under local anesthesia.
Compared to traditional vein stripping surgery, EVLA offers several advantages for patients. There is less post-operative pain and bruising, faster recovery times, and reduced risk of complications like nerve damage, deep vein thrombosis and wound infection. Studies have also shown EVLA to be more effective than surgical vein stripping at eliminating varicose veins and preventing recurrence over the long term. Various laser systems from manufacturers like AngioDynamics, Vascular Solutions and Syneron have revolutionized varicose vein care with EVLA.
Radiofrequency Ablation (RFA)
Similar to EVLA, radiofrequency ablation (RFA) uses a catheter-based varicose vein treatment device to close diseased veins non-surgically. An RFA system such as the ClosureFAST catheter from Medtronic uses radiofrequency energy delivered through a small catheter to heat and seal the vein. Like EVLA, RFA is an office-based procedure performed under local anesthesia. It effectively treats varicose veins with benefits of decreased pain, bruising, and faster recovery compared to surgery. Several studies have found RFA to be as effective as EVLA for eliminating varicosities. Both treatments provide minimally invasive alternatives to traditional vein stripping.
Foam Sclerotherapy
For smaller varicose veins treatment devices are not eligible for the endovenous catheter treatments, foam sclerotherapy is often used. This procedure involves injecting a sclerosing solution formulated as a foam into the diseased veins under ultrasound guidance. Commonly used sclerosing agents include sodium tetradecyl sulfate or polidocanol in a saline solution. When injected as a foam, it adheres to the inner lining of the vein, damaging the endothelium and causing the vein to collapse and eventually disappear. Varicose vein treatment devices like the Varithena kits help physicians safely generate and administer the sclerosing foam.
Foam sclerotherapy is usually performed in a physician's office without anesthesia. It effectively treats smaller surface veins and reticular veins just below the skin's surface that are not accessible with catheter-based techniques. Multiple treatment sessions spaced 4-6 weeks apart may be needed for complex cases. Foam sclerotherapy avoids scarring and reduces recovery time compared to surgery, making it a good first-line option for mild to moderate varicose vein disease.
Advanced Thermal Ablation Options
Newer technologies continue pushing the boundaries of minimally invasive varicose vein treatments. The Cynergy system from Medtronic uses a laser fiber and low-frequency microwave energy for enhanced heat delivery during endovenous ablation. Studies have found it provides occlusion rates comparable to conventional laser techniques but with potential benefits of less pain and quicker recovery.
Another novel device is the ClosureFast Plus radiofrequency ablation (RFA) system which chemically closes treated veins to further reduce the risk of re-opening and recurrence. Its VenaSeal glue delivery system mechanically seals veins shut and early data suggests it may provide closure rates nearing 100%. These advanced energy delivery and vein sealing technologies have the potential to make varicose vein treatments even less invasive with fewer complications and better long term effectiveness.
Managing Treatment Expectations
While minimally invasive procedures help many patients manage their varicose veins, it's important for physicians to properly set post-treatment expectations. Even with the latest varicose vein treatment devices, some minor side effects are common and patients should be counseled on reasonable recovery timeframes.
While the treated veins themselves will disappear over time, pre-existing skin and tissue changes from longstanding venous insufficiency may remain. Symptoms like aching, cramping or swelling in the legs can persist or temporarily worsen after treatment as surrounding veins adapt to increased blood flow demands. Wearing compression stockings and staying mobile aids recovery. Recurrence is still possible, usually in residual untreated veins, with rates under 10% when state-of-the-art techniques are used correctly by experienced physicians. With proper patient selection and follow up care, minimally invasive varicose vein procedures using advanced treatment devices can provide excellent clinical outcomes.
Modern varicose vein treatment devices have revolutionized care for this common condition. Minimally invasive procedures like EVLA, RFA and foam sclerotherapy safely and effectively eliminate diseased veins with less pain, fewer side effects and faster recovery compared to traditional open surgery. Continued innovations in catheter and energy delivery systems will likely push treatment effectiveness and patient benefits even higher. When performed by skilled physicians, these advanced technologies allow more patients to say goodbye to unsightly and symptomatic varicose veins.
Get more insights on this topic: https://www.ukwebwire.com/varicose-vein-treatment-devices-the-latest-advancements-in-minimally-invasive-procedures/
Explore more trending article on this topic: https://captionssky.com/industrial-laser-systems-revolutionizing-precision-manufacturing/
Transparency Market Research (TMR) has published a new report titled, ‘Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=985OverviewRadiofrequency ablation is a minimally invasive surgical procedure that involves a local anesthetic and mild sedation.
This procedure is primarily used to reduce chronic low-back and neck pain.The procedure involves heating a small area of nervous tissue under controlled temperature and as a result help in blockage of pain signals transmitting from that area.North America dominated the global radiofrequency ablation devices for pain management market in 2018 and the trend is anticipated to continue during the forecast period.
Rise in awareness regarding the treatment benefits, high incidence rate of chronic pain among the population in the U.S. are expected to drive the market in North America.However, Asia Pacific is likely to be a highly lucrative market for radiofrequency ablation devices for pain management and it is expected to expand at a high CAGR during the forecast periodGrowing adoption of RF ablation for pain management among end-users to Drive MarketPain leads to severe complications, if proper care or treatment is not taken for a long time.
High adverse effects and lower efficiency of alternate pain relief procedures and therapeutics such as opioids, acupuncture, and acupressure has led to surge in adoption of radiofrequency ablation devices, which offer better treatment with minimal side effects.Hence, high availability, easy access, increased awareness, cost-effectiveness, and quick relief provide RF ablation devices for pain management a cutting edge over other treatment options.
This is likely to augment the demand for the use of radiofrequency ablation device for pain management in the market.Request COVID Analysis on Radiofrequency Ablation Devices Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=985Disposable Products Segment to Dominate MarketBased on product type, the global radiofrequency ablation devices for pain management market is classified into RF generators, reusable products and disposable products.
Market HighlightsThe global radiofrequency ablation devices market is expected to grow at an approximate CAGR of 11.2% during the forecast period of 2018–2023.
Factors such as the advantage of radiofrequency ablation over other ablation medical procedures, the success rate of radiofrequency are driving the growth of the market.
Moreover, complications such as acute respiratory distress syndrome where success rates are low and burning sensation at the treatment site of tissue are some of the factors hindering the growth of the market.Request Sample Copyhttps://www.marketresearchfuture.com/sample_request/7634SegmentationThe global radiofrequency ablation devices market is segmented on the basis of type, application, and region.Based on the type, the global radiofrequency ablation devices market is segmented into Unipolar radiofrequency ablation and Bipolar radiofrequency ablation.
By application, the global radiofrequency ablation devices market is categorized into Surgical Oncology, Cardiology and Cardiac Rhythm Management, Gynecology, Cosmetology, Pain ManagementRegional AnalysisThe Americas dominates the global market for radiofrequency ablation devices owing to the growing geriatric population, increase in cancer cases, an increase in clinical research within the region.
Additionally, the increasing awareness about the cardiology treatment and presence of developed economies and healthcare sector within the region drives the market growth during the forecast period.
In 2017, it was estimated that Europe stood second in the global radiofrequency ablation devices market due to the increasing prevalence of gynecology, cosmetology, pain management, and others.
The Global Radiofrequency Ablation Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on product and application.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Radiofrequency Ablation Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/10376-radiofrequency-ablation-devices-market-reportThe report also covers the complete competitive landscape of the global Radiofrequency Ablation Devices market with company profiles of key players such as:Accuray Inc.AngioDynamics.Biosense WebsterBoston Scientific.Cosman Medical Inc.Covidien.DFINE Inc.Diros Technology Inc.Kimberly-Clark.NeuroTherm (St. Jude Medical).RF Medical Co. Ltd.St.
Jude Medical.STARmed.Stryker CorporationA detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Product:Capital EquipmentReusable EquipmentReusable Radiofrequency ProbesReusable Radiofrequency ElectrodesDisposable EquipmentDisposable Radiofrequency CannulasDisposable Radiofrequency NeedlesDisposable Radiofrequency Single-Use probesDisposable Radiofrequency Single-Use ElectrodesBy Applications:Surgical OncologyCardiology & Cardiac Rhythm ManagementPain ManagementGynecologyHypertensionCosmetologyBy Geography:North America (NA)Europe (EU)Asia Pacific (APAC)Rest of the World (RoW)Download Free Sample Report of Global Radiofrequency Ablation Devices Market @ https://www.decisiondatabases.com/contact/download-sample-10376The Global Radiofrequency Ablation Devices Market has been exhibited in detail in the following chapters –Chapter 1 Radiofrequency Ablation Devices Market PrefaceChapter 2 Executive SummaryChapter 3 Radiofrequency Ablation Devices Industry AnalysisChapter 4 Radiofrequency Ablation Devices Market Value Chain AnalysisChapter 5 Radiofrequency Ablation Devices Market Analysis By ProductChapter 6 Radiofrequency Ablation Devices Market Analysis By ApplicationsChapter 7 Radiofrequency Ablation Devices Market Analysis By GeographyChapter 8 Competitive Landscape Of Radiofrequency Ablation Devices CompaniesChapter 9 Company Profiles Of Radiofrequency Ablation Devices IndustryPurchase the complete Global Radiofrequency Ablation Devices Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-10376Other Reports by DecisionDatabases.com:Global Radiotherapy Equipment Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Nuclear Medicine / Radiopharmaceuticals Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
